{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:58:46Z","timestamp":1789016326162,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11010-021-04168-4","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T04:01:36Z","timestamp":1620100896000},"page":"3365-3381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["In-depth review: is hepcidin a marker for the heart and the kidney?"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5862-2334","authenticated-orcid":false,"given":"Rengin Elsurer","family":"Afsar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avsin","family":"Ibis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"4168_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/eci.12682","volume":"46","author":"MF Eisenga","year":"2016","unstructured":"Eisenga MF, Dullaart RP, Berger SP, Sloan JH, De Vries AP, Bakker SJ, Gaillard CA (2016) Association of hepcidin-25 with survival after kidney transplantation. Eur J Clin Invest 46:994\u20131001. https:\/\/doi.org\/10.1111\/eci.12682","journal-title":"Eur J Clin Invest"},{"key":"4168_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/labinvest.2017.111","volume":"98","author":"D Vela","year":"2018","unstructured":"Vela D (2018) Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology. Lab Invest 98:315\u2013326. https:\/\/doi.org\/10.1038\/labinvest.2017.111","journal-title":"Lab Invest"},{"key":"4168_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","volume":"55","author":"JL Babitt","year":"2010","unstructured":"Babitt JL, Lin HY (2010) Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis 55:726\u2013741. https:\/\/doi.org\/10.1053\/j.ajkd.2009.12.030","journal-title":"Am J Kidney Dis"},{"key":"4168_CR4","doi-asserted-by":"publisher","first-page":"e19804","DOI":"10.7554\/eLife.19804","volume":"5","author":"S Lakhal-Littleton","year":"2016","unstructured":"Lakhal-Littleton S, Wolna M, Chung YJ, Christian HC, Heather LC, Brescia M, Ball V, Diaz R, Santos A, Biggs D, Clarke K, Davies B, Robbins PA (2016) An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. Elife 5:e19804. https:\/\/doi.org\/10.7554\/eLife.19804","journal-title":"Elife"},{"key":"4168_CR5","first-page":"108","volume":"73","author":"N Van der Weerd","year":"2015","unstructured":"Van der Weerd N, Grooteman M, Nube M, Ter Wee P, Swinkels D, Gaillard CA (2015) Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker. Neth J Med 73:108\u2013118","journal-title":"Neth J Med"},{"key":"4168_CR6","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","volume":"28","author":"NC van der Weerd","year":"2013","unstructured":"van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nub\u00e9 MJ, Penne EL, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee PM, Investigators CONTRAST (2013) Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant 28:3062\u20133071. https:\/\/doi.org\/10.1093\/ndt\/gfs488","journal-title":"Nephrol Dial Transplant"},{"key":"4168_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3967\/bes2013.004","volume":"26","author":"YQ Li","year":"2013","unstructured":"Li YQ, Bai B, Zheng QQ, Yan H, Zhuang GH (2013) Quantitative study of iron metabolism-related genes expression in rat. Biomed Environ Sci 26:808\u2013819. https:\/\/doi.org\/10.3967\/bes2013.004","journal-title":"Biomed Environ Sci"},{"key":"4168_CR8","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1210\/en.2006-1331","volume":"148","author":"U Merle","year":"2007","unstructured":"Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H (2007) The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 148:2663\u20132668. https:\/\/doi.org\/10.1210\/en.2006-1331","journal-title":"Endocrinology"},{"key":"4168_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/labinvest.3700553","volume":"87","author":"N Sheikh","year":"2007","unstructured":"Sheikh N, Dudas J, Ramadori G (2007) Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat. Lab Invest 87:713\u2013725. https:\/\/doi.org\/10.1038\/labinvest.3700553","journal-title":"Lab Invest"},{"key":"4168_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cardfail.2014.01.008","volume":"20","author":"T Suzuki","year":"2014","unstructured":"Suzuki T, Hanawa H, Jiao S, Ohno Y, Hayashi Y, Yoshida K, Kashimura T, Obata H, Minamino T (2014) Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency. J Card Fail 20:268\u2013277. https:\/\/doi.org\/10.1016\/j.cardfail.2014.01.008","journal-title":"J Card Fail"},{"key":"4168_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1620\/tjem.235.69","volume":"235","author":"Y Ohno","year":"2015","unstructured":"Ohno Y, Hanawa H, Jiao S, Hayashi Y, Yoshida K, Suzuki T, Kashimura T, Obata H, Tanaka K, Watanabe T, Minamino T (2015) Liver congestion in heart failure contributes to inappropriately increased serum hepcidin despite anemia. Tohoku J Exp Med 235:69\u201379. https:\/\/doi.org\/10.1620\/tjem.235.69","journal-title":"Tohoku J Exp Med"},{"key":"4168_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000449419","volume":"44","author":"GF van Breda","year":"2016","unstructured":"van Breda GF, Bongartz LG, Zhuang W, van Swelm RP, Pertijs J, Braam B, Cramer MJ, Swinkels DW, Doevendans PA, Verhaar MC, Masereeuw R, Joles JA, Gaillard CA (2016) Cardiac hepcidin expression associates with injury independent of iron. Am J Nephrol 44:368\u2013378. https:\/\/doi.org\/10.1159\/000449419","journal-title":"Am J Nephrol"},{"key":"4168_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbagen.2019.01.010","volume":"1863","author":"J Petrak","year":"2019","unstructured":"Petrak J, Havlenova T, Krijt M, Behounek M, Franekova J, Cervenka L, Pluhacek T, Vyoral D, Melenovsky V (2019) Myocardial iron homeostasis and hepcidin expression in a rat model of heart failure at different levels of dietary iron intake. Biochim Biophys Acta Gen Subj 1863:703\u2013713. https:\/\/doi.org\/10.1016\/j.bbagen.2019.01.010","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"4168_CR14","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.118.034545","volume":"139","author":"I Zlatanova","year":"2019","unstructured":"Zlatanova I, Pinto C, Bonnin P, Mathieu JRR, Bakker W, Vilar J, Lemitre M, Voehringer D, Vaulont S, Peyssonnaux C, Silvestre JS (2019) Iron regulator hepcidin impairs macrophage-dependent cardiac repair after injury. Circulation 139:1530\u20131547. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034545","journal-title":"Circulation"},{"key":"4168_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/bs.vh.2019.01.009","volume":"110","author":"S Lakhal-Littleton","year":"2019","unstructured":"Lakhal-Littleton S (2019) Cardiomyocyte hepcidin: From intracellular iron homeostasis to physiological function. Vitam Horm 110:189\u2013200. https:\/\/doi.org\/10.1016\/bs.vh.2019.01.009","journal-title":"Vitam Horm"},{"key":"4168_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tracli.2017.06.015","volume":"24","author":"R Daher","year":"2017","unstructured":"Daher R, Karim Z (2017) Iron metabolism: state of the art. Transfus Clin Biol 24:115\u2013119. https:\/\/doi.org\/10.1016\/j.tracli.2017.06.015","journal-title":"Transfus Clin Biol"},{"key":"4168_CR17","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.peptides.2010.05.013","volume":"31","author":"G Simonis","year":"2010","unstructured":"Simonis G, Mueller K, Schwarz P, Wiedemann S, Adler G, Strasser RH, Kulaksiz H (2010) The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction. Peptides 31:1786\u20131790. https:\/\/doi.org\/10.1016\/j.peptides.2010.05.013","journal-title":"Peptides"},{"key":"4168_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1620\/tjem.218.93","volume":"218","author":"H Suzuki","year":"2009","unstructured":"Suzuki H, Toba K, Kato K, Ozawa T, Tomosugi N, Higuchi M, Kusuyama T, Iso Y, Kobayashi N, Yokoyama S, Fukuda N, Saitoh H, Akazawa K, Aizawa Y (2009) Serum hepcidin-20 is elevated during the acute phase of myocardial infarction. Tohoku J Exp Med 218:93\u201398. https:\/\/doi.org\/10.1620\/tjem.218.93","journal-title":"Tohoku J Exp Med"},{"key":"4168_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jnutbio.2009.04.009","volume":"21","author":"M Isoda","year":"2010","unstructured":"Isoda M, Hanawa H, Watanabe R, Yoshida T, Toba K, Yoshida K, Kojima M, Otaki K, Hao K, Ding L, Tanaka K, Takayama T, Kato K, Okura Y, Kodama M, Ota Y, Hayashi J, Aizawa Y (2010) Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction. J Nutr Biochem 21:749\u2013756. https:\/\/doi.org\/10.1016\/j.jnutbio.2009.04.009","journal-title":"J Nutr Biochem"},{"key":"4168_CR20","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.ijcard.2013.12.067","volume":"172","author":"Y Naito","year":"2014","unstructured":"Naito Y, Hosokawa M, Sawada H, Oboshi M, Iwasaku T, Okuhara Y, Morisawa D, Eguchi A, Hirotani S, Ohyanagi M, Tsujino T, Masuyama T (2014) Hepcidin is increased in the hypertrophied heart of Dahl salt-sensitive rats. Int J Cardiol 172:e45\u2013e47. https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.067","journal-title":"Int J Cardiol"},{"key":"4168_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2018.08.010","volume":"133","author":"S Lakhal-Littleton","year":"2019","unstructured":"Lakhal-Littleton S (2019) Mechanisms of cardiac iron homeostasis and their importance to heart function. Free Radic Biol Med 133:234\u2013237. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.08.010","journal-title":"Free Radic Biol Med"},{"key":"4168_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/ATVBAHA.113.302381","volume":"34","author":"TE Galesloot","year":"2014","unstructured":"Galesloot TE, Holewijn S, Kiemeney LA, de Graaf J, Vermeulen SH, Swinkels DW (2014) Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population. Arterioscler Thromb Vasc Biol 34:446\u2013456. https:\/\/doi.org\/10.1161\/ATVBAHA.113.302381","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4168_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1515\/cclm-2015-0068","volume":"54","author":"R Pechlaner","year":"2016","unstructured":"Pechlaner R, Kiechl S, Mayr M, Santer P, Weger S, Haschka D, Bansal SS, Willeit J, Weiss G (2016) Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population. Clin Chem Lab Med 54:151\u2013161. https:\/\/doi.org\/10.1515\/cclm-2015-0068","journal-title":"Clin Chem Lab Med"},{"key":"4168_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12944-018-0866-6","volume":"17","author":"X Wang","year":"2018","unstructured":"Wang X, Sheng L, Ye P, Cao R, Yang X, Xiao W, Zhang Y, Bai Y, Wu H (2018) The association between Hepcidin and arterial stiffness in a community-dwelling population. Lipids Health Dis 17:244. https:\/\/doi.org\/10.1186\/s12944-018-0866-6","journal-title":"Lipids Health Dis"},{"key":"4168_CR25","doi-asserted-by":"publisher","first-page":"158531","DOI":"10.1016\/j.bbalip.2019.158531","volume":"1865","author":"L Xiao","year":"2020","unstructured":"Xiao L, Luo G, Guo X, Jiang C, Zeng H, Zhou F, Li Y, Yu J, Yao P (2020) Macrophage iron retention aggravates atherosclerosis: evidence for the role of autocrine formation of hepcidin in plaque macrophages. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158531. https:\/\/doi.org\/10.1016\/j.bbalip.2019.158531","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"4168_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3181\/0703-MR-54","volume":"232","author":"JL Sullivan","year":"2007","unstructured":"Sullivan JL (2007) Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med (Maywood) 232:1014\u20131020. https:\/\/doi.org\/10.3181\/0703-MR-54","journal-title":"Exp Biol Med (Maywood)"},{"issue":"65","key":"4168_CR27","doi-asserted-by":"publisher","first-page":"109497","DOI":"10.18632\/oncotarget.22722","volume":"8","author":"X Li","year":"2017","unstructured":"Li X, Ding D, Zhang Y, Su D, Wang M, Chen X, Yang Y, Hong C, Hu G, Ling W (2017) Associations of plasma hepcidin with mortality risk in patients with coronary artery disease. Oncotarget 8(65):109497. https:\/\/doi.org\/10.18632\/oncotarget.22722","journal-title":"Oncotarget"},{"key":"4168_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jtcvs.2012.09.003","volume":"145","author":"A Haase-Fielitz","year":"2013","unstructured":"Haase-Fielitz A, Pla\u00df M, Kuppe H, Hetzer R, Ostland V, Westphal S, Hoffmann J, Prowle J, Mertens PR, Westerman M, Bellomo R, Haase M (2013) Low preoperative hepcidin concentration as a risk factor for mortality after cardiac surgery: A pilot study. J Thorac Cardiovasc Surg 145:1380\u20131386. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.09.003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4168_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biom8030043","volume":"8","author":"T Zeller","year":"2018","unstructured":"Zeller T, Altay A, Waldeyer C, Appelbaum S, Ojeda F, Ruhe J, Schnabel RB, Lackner KJ, Blankenberg S, Karakas M (2018) Prognostic value of iron-homeostasis regulating peptide hepcidin in coronary heart disease\u2014evidence from the large atherogene study. Biomolecules 8:43. https:\/\/doi.org\/10.3390\/biom8030043","journal-title":"Biomolecules"},{"key":"4168_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/biom8030072","volume":"8","author":"J Ruhe","year":"2018","unstructured":"Ruhe J, Waldeyer C, Ojeda F, Altay A, Schnabel RB, Schaefer S, Lackner KJ, Blankenberg S, Zeller T, Karakas M (2018) Intrinsic iron release is associated with lower mortality in patients with stable coronary artery disease: first report on the prospective relevance of intrinsic iron release. Biomolecules 8:72. https:\/\/doi.org\/10.3390\/biom8030072","journal-title":"Biomolecules"},{"key":"4168_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1373\/clinchem.2018.297242","volume":"65","author":"TB Grammer","year":"2019","unstructured":"Grammer TB, Scharnagl H, Dressel A, Kleber ME, Silbernagel G, Pilz S, Tomaschitz A, Koenig W, Mueller-Myhsok B, M\u00e4rz W, Strnad P (2019) Iron metabolism, hepcidin, and mortality (the Ludwigshafen Risk and Cardiovascular Health Study). Clin Chem 65:849\u2013861. https:\/\/doi.org\/10.1373\/clinchem.2018.297242","journal-title":"Clin Chem"},{"key":"4168_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1681\/ASN.2018100979","volume":"30","author":"DE Leaf","year":"2019","unstructured":"Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS (2019) Iron, hepcidin, and death in human AKI. J Am Soc Nephrol 30:493\u2013504. https:\/\/doi.org\/10.1681\/ASN.2018100979","journal-title":"J Am Soc Nephrol"},{"key":"4168_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ejhf.622","volume":"19","author":"IT Klip","year":"2017","unstructured":"Klip IT, Voors AA, Swinkels DW, Bakker SJ, Kootstra-Ros JE, Lam CS, van der Harst P, van Veldhuisen DJ, van der Meer P (2017) Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community. Eur J Heart Fail 19:348\u2013356. https:\/\/doi.org\/10.1002\/ejhf.622","journal-title":"Eur J Heart Fail"},{"key":"4168_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/biof.1468","volume":"45","author":"D Vela","year":"2019","unstructured":"Vela D (2019) Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology. BioFactors 45:118\u2013134. https:\/\/doi.org\/10.1002\/biof.1468","journal-title":"BioFactors"},{"key":"4168_CR35","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3346\/jkms.2020.35.e2","volume":"35","author":"HK Min","year":"2019","unstructured":"Min HK, Oh YK, Choi KH, Lee KB, Park SK, Ahn C, Lee SW (2019) Relationship between cardiac geometry and serum hepcidin in chronic kidney disease: analysis from the KNOW-CKD Study. J Korean Med Sci 35:e2. https:\/\/doi.org\/10.3346\/jkms.2020.35.e2","journal-title":"J Korean Med Sci"},{"key":"4168_CR36","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s11255-014-0753-7","volume":"46","author":"SM Ulu","year":"2014","unstructured":"Ulu SM, Yuksel S, Altunta\u015f A, Kacar E, Ahsen A, Altug A, Celik S, Sezer MT (2014) Associations between serum hepcidin level, FGF-21 level and oxidative stress with arterial stiffness in CAPD patients. Int Urol Nephrol 46:2409\u20132414. https:\/\/doi.org\/10.1007\/s11255-014-0753-7","journal-title":"Int Urol Nephrol"},{"key":"4168_CR37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/ki.2008.316","volume":"74","author":"X Zhang","year":"2008","unstructured":"Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, Green-Church K, Nagaraja H, Birmingham DJ, Yu CY, Hebert LA, Rovin BH (2008) Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 74:799\u2013807. https:\/\/doi.org\/10.1038\/ki.2008.316","journal-title":"Kidney Int"},{"key":"4168_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ki.2011.354","volume":"81","author":"X Zhang","year":"2012","unstructured":"Zhang X, Nagaraja HN, Nadasdy T, Song H, McKinley A, Prosek J, Kamadana S, Rovin BH (2012) A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int 81:401\u2013406. https:\/\/doi.org\/10.1038\/ki.2011.354","journal-title":"Kidney Int"},{"key":"4168_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ndt\/gfv012","volume":"30","author":"GD Fufaa","year":"2015","unstructured":"Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M, CKD Biomarkers Consortium and the RASS Investigators (2015) Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus. Nephrol Dial Transplant 30:599\u2013606. https:\/\/doi.org\/10.1093\/ndt\/gfv012","journal-title":"Nephrol Dial Transplant"},{"key":"4168_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11255-020-02434-w","volume":"52","author":"ZS Hayder","year":"2020","unstructured":"Hayder ZS, Kareem ZS (2020) Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin. Int Urol Nephrol 52:749\u2013756. https:\/\/doi.org\/10.1007\/s11255-020-02434-w","journal-title":"Int Urol Nephrol"},{"key":"4168_CR41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/ndt\/gfr387","volume":"27","author":"JR Prowle","year":"2012","unstructured":"Prowle JR, Ostland V, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Bagshaw SM, Haase-Fielitz A, Haase M, Westerman M, Bellomo R (2012) Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass. Nephrol Dial Transplant 27:595\u2013602. https:\/\/doi.org\/10.1093\/ndt\/gfr387","journal-title":"Nephrol Dial Transplant"},{"key":"4168_CR42","doi-asserted-by":"publisher","first-page":"e0123072","DOI":"10.1371\/journal.pone.0123072","volume":"10","author":"M Wagner","year":"2015","unstructured":"Wagner M, Ashby DR, Kurtz C, Alam A, Busbridge M, Raff U, Zimmermann J, Heuschmann PU, Wanner C, Schramm L (2015) Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease. PLoS ONE 10:e0123072. https:\/\/doi.org\/10.1371\/journal.pone.0123072","journal-title":"PLoS ONE"},{"key":"4168_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.freeradbiomed.2018.06.025","volume":"133","author":"T Nakanishi","year":"2019","unstructured":"Nakanishi T, Kuragano T, Nanami M, Nagasawa Y, Hasuike Y (2019) Misdistribution of iron and oxidative stress in chronic kidney disease. Free Radic Biol Med 133:248\u2013253. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.025","journal-title":"Free Radic Biol Med"},{"key":"4168_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5527\/wjn.v2.i2.38","volume":"2","author":"YP Hsieh","year":"2013","unstructured":"Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC (2013) Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2:38\u201343. https:\/\/doi.org\/10.5527\/wjn.v2.i2.38","journal-title":"World J Nephrol"},{"key":"4168_CR45","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/ndt\/gfq760","volume":"26","author":"T Kuragano","year":"2011","unstructured":"Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, Yahiro M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T (2011) Hepcidin as well as TNF-\u03b1 are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant 26:2663\u20132667. https:\/\/doi.org\/10.1093\/ndt\/gfq760","journal-title":"Nephrol Dial Transplant"},{"key":"4168_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12882-019-1367-1","volume":"20","author":"M Cano-Meg\u00edas","year":"2019","unstructured":"Cano-Meg\u00edas M, Guisado-Vasco P, Bouarich H, de la Fuente GA, de Sequera-Ortiz P, \u00c1lvarez-Sanz C, Rodr\u00edguez-Puyol D (2019) Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study. BMC Nephrol 20:188. https:\/\/doi.org\/10.1186\/s12882-019-1367-1","journal-title":"BMC Nephrol"},{"key":"4168_CR47","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.3899\/jrheum.110339","volume":"38","author":"MA Abdel-Khalek","year":"2011","unstructured":"Abdel-Khalek MA, El-Barbary AM, Essa SA-M, Ghobashi AS (2011) Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. J Rheumatol 38:2153\u20132159. https:\/\/doi.org\/10.3899\/jrheum.110339","journal-title":"J Rheumatol"},{"key":"4168_CR48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/jcm8040523","volume":"8","author":"B Spoto","year":"2019","unstructured":"Spoto B, Kakkar R, Lo L, Devalaraja M, Pizzini P, Torino C, Leonardis D, Cutrupi S, Tripepi G, Mallamaci F, Zoccali C (2019) Serum erythroferrone levels associate with mortality and cardiovascular events in hemodialysis and in CKD patients: a two cohorts study. J Clin Med 8:523. https:\/\/doi.org\/10.3390\/jcm8040523","journal-title":"J Clin Med"},{"key":"4168_CR49","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/164_2017_30","volume":"243","author":"EA Jankowska","year":"2017","unstructured":"Jankowska EA, Drozd M, Ponikowski P (2017) Iron deficiency treatment in patients with heart failure. Handb Exp Pharmacol 243:561\u2013576. https:\/\/doi.org\/10.1007\/164_2017_30","journal-title":"Handb Exp Pharmacol"},{"key":"4168_CR50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijcard.2014.02.016","volume":"173","author":"A Florian","year":"2014","unstructured":"Florian A, Ludwig A, R\u00f6sch S, Yildiz H, Klumpp S, Sechtem U, Yilmaz A (2014) Positive effect of intravenous iron-oxide administration on left ventricular remodelling in patients with acute ST-elevation myocardial infarction\u2013A cardiovascular magnetic resonance (CMR) study. Int J Cardiol 173:184\u2013189. https:\/\/doi.org\/10.1016\/j.ijcard.2014.02.016","journal-title":"Int J Cardiol"},{"key":"4168_CR51","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3892\/mmr.2016.5705","volume":"14","author":"M Dziegala","year":"2016","unstructured":"Dziegala M, Kasztura M, Kobak K, Bania J, Banasiak W, Ponikowski P, Jankowska EA (2016) Influence of the availability of iron during hypoxia on the genes associated with apoptotic activity and local iron metabolism in rat H9C2 cardiomyocytes and L6G8C5 skeletal myocytes. Mol Med Rep 14:3969\u20133977. https:\/\/doi.org\/10.3892\/mmr.2016.5705","journal-title":"Mol Med Rep"},{"key":"4168_CR52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/eurheartj\/ehw333","volume":"38","author":"S Haddad","year":"2017","unstructured":"Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, Rostami F, Reboll MR, Heineke J, Fl\u00f6gel U, Groos S, Renner A, Toischer K, Zimmermann F, Engeli S, Jordan J, Bauersachs J, Hentze MW, Wollert KC, Kempf T (2017) Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J 38:362\u2013372. https:\/\/doi.org\/10.1093\/eurheartj\/ehw333","journal-title":"Eur Heart J"},{"key":"4168_CR53","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/ATVBAHA.112.246108","volume":"32","author":"JJ Li","year":"2012","unstructured":"Li JJ, Meng X, Si HP, Zhang C, Lv HX, Zhao YX, Yang JM, Dong M, Zhang K, Liu SX, Zhao XQ, Gao F, Liu XL, Cui TX, Zhang Y (2012) Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Arterioscler Thromb Vasc Biol 32:1158\u20131166. https:\/\/doi.org\/10.1161\/ATVBAHA.112.246108","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4168_CR54","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/ATVBAHA.110.214858","volume":"31","author":"L Valenti","year":"2011","unstructured":"Valenti L, Dongiovanni P, Motta BM, Swinkels DW, Bonara P, Rametta R, Burdick L, Frugoni C, Fracanzani AL, Fargion S (2011) Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol 31:683\u2013690. https:\/\/doi.org\/10.1161\/ATVBAHA.110.214858","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4168_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1161\/ATVBAHA.111.240101","volume":"32","author":"O Saeed","year":"2012","unstructured":"Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, Rostad B, Pachura K, Adams L, Elliott J, Taylor WR, Narula J, Kolodgie F, Virmani R, Hong CC, Finn AV (2012) Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol 32:299\u2013307. https:\/\/doi.org\/10.1161\/ATVBAHA.111.240101","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4168_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11010-010-0484-8","volume":"342","author":"H Geng","year":"2010","unstructured":"Geng H, Wang A, Rong G, Zhu B, Deng Y, Chen J, Zhong R (2010) The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway. Mol Cell Biochem 342:201\u2013206. https:\/\/doi.org\/10.1007\/s11010-010-0484-8","journal-title":"Mol Cell Biochem"},{"key":"4168_CR57","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1161\/hc5001.100631","volume":"104","author":"XH Xu","year":"2001","unstructured":"Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104:3103\u20133108. https:\/\/doi.org\/10.1161\/hc5001.100631","journal-title":"Circulation"},{"key":"4168_CR58","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","volume":"111","author":"I Theurl","year":"2008","unstructured":"Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, Bellmann-Weiler R, Niederegger H, Talasz H, Weiss G (2008) Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111:2392\u20132399. https:\/\/doi.org\/10.1182\/blood-2007-05-090019","journal-title":"Blood"},{"key":"4168_CR59","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1182\/blood-2005-06-2259","volume":"107","author":"C Peyssonnaux","year":"2006","unstructured":"Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V (2006) TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107:3727\u20133732. https:\/\/doi.org\/10.1182\/blood-2005-06-2259","journal-title":"Blood"},{"key":"4168_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s1097-2765(01)00164-2","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P (2001) A PPAR\u03b3-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7:161\u2013171. https:\/\/doi.org\/10.1016\/s1097-2765(01)00164-2","journal-title":"Mol Cell"},{"key":"4168_CR61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/ATVBAHA.118.312215","volume":"39","author":"R Malhotra","year":"2019","unstructured":"Malhotra R, Wunderer F, Barnes HJ, Bagchi A, Buswell MD, O\u2019Rourke CD, Slocum CL, Ledsky CD, Peneyra KM, Sigurslid H, Corman B, Johansson KB, Rhee DK, Bloch KD, Bloch DB (2019) Hepcidin deficiency protects against atherosclerosis. Arterioscler Thromb Vasc Biol 39:178\u2013187. https:\/\/doi.org\/10.1161\/ATVBAHA.118.312215","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4168_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10354-016-0505-7","volume":"166","author":"M Nairz","year":"2016","unstructured":"Nairz M, Theurl I, Wolf D, Weiss G (2016) Iron deficiency or anemia of inflammation? Differential diagnosis and mechanisms of anemia of inflammation. Wien Med Wochenschr 166:411\u2013423. https:\/\/doi.org\/10.1007\/s10354-016-0505-7","journal-title":"Wien Med Wochenschr"},{"key":"4168_CR63","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","volume":"127","author":"D Girelli","year":"2016","unstructured":"Girelli D, Nemeth E, Swinkels DW (2016) Hepcidin in the diagnosis of iron disorders. Blood 127:2809\u20132813. https:\/\/doi.org\/10.1182\/blood-2015-12-639112","journal-title":"Blood"},{"key":"4168_CR64","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3324\/haematol.2019.232124","volume":"105","author":"C Camaschella","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L (2020) Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica 105:260\u2013272. https:\/\/doi.org\/10.3324\/haematol.2019.232124","journal-title":"Haematologica"},{"key":"4168_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.krcp.2013.01.001","volume":"32","author":"DS Larson","year":"2013","unstructured":"Larson DS, Coyne DW (2013) Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease. Kidney Res Clin Pract 32:11\u201315. https:\/\/doi.org\/10.1016\/j.krcp.2013.01.001","journal-title":"Kidney Res Clin Pract"},{"key":"4168_CR66","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","volume":"117","author":"TE Galesloot","year":"2011","unstructured":"Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, Wetzels JF, Kiemeney LA, Sweep FC, den Heijer M, Swinkels DW (2011) Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 117:e218\u2013e225. https:\/\/doi.org\/10.1182\/blood-2011-02-337907","journal-title":"Blood"},{"key":"4168_CR67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","volume":"89","author":"IC Macdougall","year":"2016","unstructured":"Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM, Participants C (2016) Iron management in chronic kidney disease: conclusions from a \u201cKidney disease: improving global outcomes\u201d(KDIGO) controversies conference. Kidney Int 89:28\u201339. https:\/\/doi.org\/10.1016\/j.kint.2015.10.002","journal-title":"Kidney Int"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04168-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T15:18:32Z","timestamp":1628176712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04168-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4168"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04168-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent for publication: On behalf of all the authors, the corresponding Author declares that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere. He declares that the manuscript has been read and approved by all named authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}